Envista (NVST) reported $750.6 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 15%. EPS of $0.38 for the same period compares to $0.24 a year ago.The reported revenue represents a surprise of +11.16% over the Zacks Consensus Estimate of $675.26 million. With the consensus EPS estimate being $0.32, the EPS surprise was +18.23%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stree ...

Envista (NVST) came out with quarterly earnings of $0.38 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to earnings of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.23%. A quarter ago, it was expected that this maker of dental products would post earnings of $0.27 per share when it actually produced earnings of $0.32, delivering a surprise of +18.52%.Over the last four quarters, t ...

Envista (NYSE:NVST) Q4 2025 Earnings call February 05, 2026 05:00 PM ET Company ParticipantsElizabeth Anderson - Senior Managing DirectorEric Hammes - CFOJim Gustafson - VP of Investor RelationsJonathan Block - Managing DirectorKevin Caliendo - Healthcare Equity ResearchLilly Quezada - Senior Branch ManagerPaul Keel - CEOConference Call ParticipantsBrandon Vazquez - Research AnalystJeffrey Johnson - Senior Research AnalystSteven Valiquette - Managing Director and Senior Equity Research AnalystNone - Analyst ...

Envista (NYSE:NVST) Q4 2025 Earnings call February 05, 2026 05:00 PM ET Company ParticipantsElizabeth Anderson - Senior Managing DirectorEric Hammes - CFOJim Gustafson - VP of Investor RelationsJonathan Block - Managing DirectorKevin Caliendo - Healthcare Equity ResearchLilly Quezada - Senior Branch ManagerPaul Keel - CEOConference Call ParticipantsBrandon Vazquez - Research AnalystJeffrey Johnson - Senior Research AnalystSteven Valiquette - Managing Director and Senior Equity Research AnalystNone - Analyst ...

Envista (NYSE:NVST) Q4 2025 Earnings call February 05, 2026 05:00 PM ET Speaker2Hello, my name is Vanessa, and I will be your conference call facilitator this afternoon. At this time, I would like to welcome everyone to Envista Holdings Corporation's fourth quarter 2025 earnings results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, please pres ...

Q4 2025 Results Paul Keel, CEO February 5, 2026 Forward looking statements/Non-GAAP financial measures FORWARD-LOOKING STATEMENTS Certain statements in this presentation are "forward-looking statements" within the meaning of the U.S. federal securities laws, including statements regarding future financial performance, and the objectives and expectations of management. Terminology such as "believe," "anticipate," "should," "could," "intend," "will," "plan," "expect," "estimate," "project," "target," "may," " ...

Exhibit 99.1 Envista Reports Fourth Quarter 2025 Results BREA, Calif., February 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO. "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2 ...

BREA, Calif., Feb. 5, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended December 31, 2025. "With our disciplined focus on Growth, Operations, and People, Q4 2025 marked another quarter of continued progress for Envista," said Paul Keel, CEO. "We delivered 10.8% core revenue growth and 22% adjusted EBITDA growth in Q425, and 6.5% core revenue growth and 26% EBITDA growth for the full-year 2025. In the process, we posted positive growth in all major b ...

Core Viewpoint - The upcoming 4Q/FY25 results for NVST are anticipated to exceed analysts' conservative forecasts, potentially leading to a re-rating of its shares [1]. Group 1: Company Overview - NVST is set to release its financial results next week, which is a significant event for investors [1]. - The analysis suggests that the current market expectations for NVST's earnings are overly cautious [1]. Group 2: Investment Strategy - The focus is on identifying Asia-listed stocks that exhibit a substantial gap between their market price and intrinsic value, particularly in the context of deep value balance sheet bargains and wide moat stocks [1][2]. - The investment strategy includes targeting stocks that are undervalued based on metrics such as net cash, low price-to-book ratios, and sum-of-the-parts discounts [1].

Core Viewpoint - The comparison between Envista (NVST) and Stryker (SYK) indicates that NVST is currently a more attractive option for value investors due to its stronger earnings outlook and favorable valuation metrics [1][2]. Valuation Metrics - Envista has a forward P/E ratio of 19.27, while Stryker's forward P/E is 23.99, suggesting that NVST is more reasonably priced relative to its earnings [4]. - The PEG ratio for NVST is 1.08, indicating a better valuation when considering expected earnings growth, compared to SYK's PEG ratio of 2.30 [4]. - Envista's P/B ratio stands at 1.29, significantly lower than Stryker's P/B ratio of 6.31, further supporting NVST's position as a better value option [5]. Investment Grades - Envista holds a Zacks Rank of 2 (Buy), while Stryker has a Zacks Rank of 3 (Hold), reflecting a more favorable earnings outlook for NVST [2]. - Based on valuation figures, Envista has a Value grade of B, whereas Stryker has a Value grade of C, indicating that NVST is the superior value option at this time [5].